(NASDAQ: CARL) Carlsmed's forecast annual revenue growth rate of 34.08% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.72%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.94%.
Carlsmed's revenue in 2026 is $63,295,000.On average, 7 Wall Street analysts forecast CARL's revenue for 2026 to be $2,136,330,429, with the lowest CARL revenue forecast at $2,032,716,519, and the highest CARL revenue forecast at $2,207,426,772. On average, 7 Wall Street analysts forecast CARL's revenue for 2027 to be $3,010,673,471, with the lowest CARL revenue forecast at $2,720,882,156, and the highest CARL revenue forecast at $3,314,006,945.
In 2028, CARL is forecast to generate $4,180,596,008 in revenue, with the lowest revenue forecast at $3,848,594,653 and the highest revenue forecast at $4,655,663,736.